Which Cannabis Strains Are Good for Pain? What the Research Actually Says

Which Cannabis Strains Are Good for Pain? What the Research Actually Says

Medical disclaimer: This article is for general educational and cultivation-interest purposes only. It is not medical advice and should not be used to diagnose, treat, or cure any condition. Research on cannabis and pain is still developing and results are mixed. If you are managing chronic pain or any medical condition, please consult a qualified healthcare professional before making any decisions about cannabis or any other substance. Skyline Smoke Company sells cannabis seeds in South Africa as novelty and souvenir items for collectors and home growers, in line with the private-use framework discussed in our South African cannabis laws guide. We do not sell, market, or represent any seed as medicine or as a treatment for pain or any other condition.

Cannabis has a long history of traditional use for pain and discomfort, and it's one of the most common reasons people say they use it today. But the science is more nuanced than a lot of online guides suggest: some reviews report modest benefits for certain types of pain, while several recent high-quality reviews found the evidence to be weak or inconclusive. This guide walks through what's actually known, how THC, CBD and terpenes are thought to interact with the body, and what to consider if you're interested in cannabis genetics for home growing.

In this guide we cover:

  • How cannabis is thought to interact with pain signalling
  • What current research does and doesn't support
  • Indica vs sativa vs hybrid genetics, in general terms
  • Popular strain genetics and their commonly reported (anecdotal) effects
  • Terpenes and how they may influence effects
  • Consumption methods and general dosing concepts
  • The legal status of cannabis and seeds in South Africa

How Cannabis May Interact With Pain Signalling

Cannabis compounds are thought to interact with the endocannabinoid system (ECS), a network of receptors involved in regulating pain signalling, inflammation, mood, appetite and immune response. This is why cannabinoids are of scientific interest for pain, but interest and preliminary evidence are not the same as proof of effectiveness for any specific condition.

Key Cannabinoids Being Studied for Pain

THC (Tetrahydrocannabinol)

  • The main psychoactive cannabinoid; some studies suggest it may reduce pain perception in certain people
  • Often reported to promote relaxation and sleepiness
  • Higher doses increase the risk of side effects like anxiety, dizziness or paranoia (see our guide on preventing cannabis-induced paranoia)

CBD (Cannabidiol)

  • Non-intoxicating; some research points to anti-inflammatory properties, though clinical results for pain specifically are mixed — see our full breakdown in the science behind the benefits of CBD products
  • Frequently used alongside THC rather than alone

CBG & CBN

  • Minor cannabinoids with early-stage, preliminary research into possible analgesic properties; far less studied than THC or CBD

Some researchers propose an "entourage effect" where cannabinoids and terpenes work together, but this theory is still being tested and isn't yet confirmed by strong clinical evidence.

What Does the Research Actually Say?

Evidence on cannabis and pain has shifted over time:

  • A widely cited 2017 U.S. National Academies of Sciences report concluded there was substantial evidence supporting cannabis or cannabinoids for chronic pain in adults.
  • More recent, higher-quality reviews have been considerably more cautious. A Cochrane review of cannabis-based medicines for chronic neuropathic pain (21 studies, over 2,000 participants) found no clear evidence of a meaningful pain-relief effect over placebo, and called the overall evidence weak and uncertain.
  • A 2025 update published in the Annals of Internal Medicine, reviewing 25 randomised controlled trials, found that some THC-containing products may produce a small reduction in pain scores, but the effect sizes were modest rather than dramatic.
  • Reviews specifically looking at nerve (neuropathic) pain have found the supporting evidence falls short of confirming cannabis as a reliable treatment.

The honest summary: cannabis may help some people with some types of pain to some degree, but it is not a proven cure, results vary a lot between individuals, and it should not replace medical treatment or advice from a healthcare professional.

Indica vs Sativa vs Hybrid: Does the Category Matter for Effects?

Historically, indica, sativa and hybrid labels have been used as a shorthand for expected effects, though researchers increasingly note that a strain's actual chemical profile (cannabinoids and terpenes) matters more than its indica/sativa/hybrid label. With that caveat in mind, here's how each category is generally described by growers and users:

Indica-dominant genetics

Commonly described as producing deeper body relaxation and sedation, which is why they're often used in the evening.

Sativa-dominant genetics

Commonly described as more uplifting and energising, often favoured for daytime use.

Hybrid genetics

A blend of indica and sativa lineage, bred to balance relaxing and uplifting effects.

Popular Strain Genetics: Reported Effect Profiles

Important: the seeds below are sold by Skyline as novelty and souvenir items for adult collectors and home growers operating within South Africa's private-use framework. They are not sold, labelled, or intended as medicine, and none of the descriptions below are medical claims — they reflect general characteristics commonly reported by growers and cannabis communities, not guaranteed or clinically confirmed effects. Always check current South African law (see our legal guide) before cultivating.

Genetics Type Typical THC Commonly Reported Effects (anecdotal)
Northern Lights Indica 16–21% Deep relaxation, sedating, calming
Granddaddy Purple Indica 17–23% Heavily relaxing, associated with sleepiness
Bubba Kush Indica 18–25% Physically relaxing, calming
White Widow Hybrid 18–25% Balanced, described as euphoric and fast-acting
Blue Dream Sativa-hybrid 17–24% Described as clear-headed and relaxing
Girl Scout Cookies Hybrid 18–28% Long-lasting, strong relaxation
OG Kush Hybrid 19–26% Potent body and head effects
ACDC CBD-dominant hybrid <6% (CBD 15–25%) Non-intoxicating, mellow
Harlequin CBD-rich hybrid CBD 10–15% Balanced, described as clear-headed
Sour Diesel Sativa 20–26% Energising, described as uplifting
Gelato Hybrid 20–25% Relaxing with an uplifting edge
Wedding Cake Hybrid 22–28% Strong, heavy-bodied relaxation
Afghan Kush Indica 17–22% Classic full-body relaxation
Purple Punch Indica 18–25% Fast-acting, sedating
Pineapple Express Hybrid 18–24% Functional, moderate daytime relaxation

Terpenes: Do They Change the Effects?

Terpenes are aromatic compounds found throughout the plant kingdom, including cannabis. Early research suggests some terpenes may modestly influence how a strain feels, though — like cannabinoids — most terpene-specific pain claims are still preliminary. Read our full breakdown in What Are Terpenes and How Do They Affect You?

  • Myrcene — commonly associated with sedative, muscle-relaxing effects
  • Caryophyllene — unusual among terpenes in that it can bind to cannabinoid receptors directly; of interest for inflammation research
  • Limonene — associated with mood elevation
  • Linalool — associated with calming, anti-anxiety effects

THC vs CBD: Which Is "Better" for Pain?

Neither cannabinoid is universally better — they tend to be used for different goals, and individual response varies widely:

THC

  • More intoxicating; some studies suggest a modestly stronger pain-relief effect for certain pain types
  • May aid sleep in some users, but can also cause anxiety at higher doses

CBD

  • Non-intoxicating
  • Popular for general wellness use, though robust clinical evidence for pain specifically remains limited

Many users report that balanced THC:CBD ratios feel more manageable than THC alone, though this is based on user reports rather than strong clinical trial data.

Common Consumption Methods

For a full comparison of every option, see our guide to all the methods of consuming cannabis.

Smoking / Vaping

  • Fast onset
  • Effects wear off relatively quickly

Edibles

  • Slower onset (roughly 1–2 hours)
  • Effects generally last longer

Tinctures & Oils

  • Allows more precise dosing
  • Faster onset than edibles when taken sublingually

Topicals

  • Applied directly to the skin
  • Generally non-intoxicating since minimal THC reaches the bloodstream

General Dosing Concepts

These figures are commonly cited starting points in harm-reduction literature — they are general information, not medical dosing instructions. Individual tolerance varies enormously.

Method Commonly Cited Starting Point
Smoking/Vaping 1–2 small inhalations, then wait
Edibles 2.5–5mg THC
Oils/Tinctures 2–5mg THC
CBD products 10–25mg

The standard harm-reduction advice is to start low and go slow, and to speak with a healthcare professional before using cannabis alongside any medication or existing health condition.

Conditions People Commonly Associate With Cannabis Use

People report using cannabis in connection with a wide range of conditions, including arthritis, fibromyalgia, chronic back pain, multiple sclerosis-related discomfort, migraines, sciatica, neuropathy, sports injuries and post-surgical discomfort. Listing these is not an endorsement of cannabis as a proven treatment for any of them — evidence quality varies significantly between conditions, and in several cases (including neuropathic pain) recent reviews found the evidence too weak to draw firm conclusions. Anyone managing one of these conditions should talk to a doctor about evidence-based treatment options.

Weighing the Risks

Some research suggests cannabis carries a lower overdose risk than opioids, and some users report fewer side effects than with certain pharmaceutical pain medications. However, cannabis is not risk-free: possible side effects include dry mouth, drowsiness, dizziness, increased appetite, and — particularly at higher THC doses — anxiety or paranoia. Regular use can also lead to dependence in some people. None of this is a substitute for professional medical guidance.

Legal Status of Cannabis and Seeds in South Africa

Private cannabis use and cultivation for personal purposes is decriminalised in South Africa following the Constitutional Court ruling and the subsequent Cannabis for Private Purposes Act, with draft regulations (published February 2026) proposing limits such as up to 750g and five plants per adult in a private space. Commercial sale of cannabis itself remains tightly restricted to licensed medicinal and industrial hemp channels — it is not general retail. Skyline sells cannabis seeds strictly as novelty and souvenir collector items, not as cannabis, and not as medicine. For the full picture, see our Current Cannabis Laws in South Africa (2026) guide, and always confirm the latest regulations before growing.

Frequently Asked Questions

Does cannabis cure chronic pain?

No. Cannabis is not a proven cure for chronic pain. Some reviews report modest, short-term reductions in pain scores for certain THC-containing products, while other recent high-quality reviews found no clear benefit over placebo. This is not medical advice — speak with a healthcare professional about proven treatment options.

Is THC or CBD better for pain?

Neither is definitively "better" — they work differently and affect people differently. THC is more likely to be intoxicating and is associated with a modestly stronger effect in some studies, while CBD is non-intoxicating with more limited pain-specific evidence. Many users report balanced THC:CBD products feel more manageable, based on anecdotal reports rather than strong trial data.

Can I legally buy cannabis seeds in South Africa?

Skyline sells cannabis seeds as novelty and souvenir items for adult collectors and home growers, consistent with South Africa's private-use framework. Laws around cultivation limits are still being finalised through draft regulations — see our legal guide for the current position.

Does Skyline sell cannabis or seeds as medicine?

No. Skyline does not sell, market, or represent any cannabis seed as medicine or as a treatment for pain or any other condition. Our seeds are sold strictly as novelty and souvenir collector items.

Why does the research on cannabis and pain seem to contradict itself?

Because it does, to some extent. Earlier reports (such as a widely cited 2017 U.S. National Academies review) described substantial evidence for chronic pain, while more recent, higher-quality systematic reviews (including Cochrane and Annals of Internal Medicine reviews published in 2025–2026) found the evidence for many pain types to be weak, mixed, or inconclusive. Research quality and methods have improved over time, which is part of why conclusions have become more cautious.

At Skyline Smoke Company, we stock a wide range of cannabis seed genetics for South African collectors and home growers, sourced from reputable breeders. Browse our full cannabis seed collection to explore genetics by type — all sold as novelty and souvenir items, never as medicine.

Back to blog

Leave a comment

Please note, comments need to be approved before they are published.